| 000 | 01546 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516174545.0 | ||
| 264 | 0 | _c20150219 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1873-2402 | ||
| 024 | 7 |
_a10.1016/j.biopsych.2013.08.033 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCasey, Kevin F | |
| 245 | 0 | 0 |
_aReduced dopamine response to amphetamine in subjects at ultra-high risk for addiction. _h[electronic resource] |
| 260 |
_bBiological psychiatry _cJul 2014 |
||
| 300 |
_a23-30 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmphetamine _xpharmacology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xpharmacology |
| 650 | 0 | 4 |
_aCorpus Striatum _xdiagnostic imaging |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDopamine Antagonists |
| 650 | 0 | 4 | _aFamily Health |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFunctional Neuroimaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aProdromal Symptoms |
| 650 | 0 | 4 | _aRaclopride |
| 650 | 0 | 4 |
_aSubstance-Related Disorders _xdiagnosis |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBenkelfat, Chawki | |
| 700 | 1 | _aCherkasova, Mariya V | |
| 700 | 1 | _aBaker, Glen B | |
| 700 | 1 | _aDagher, Alain | |
| 700 | 1 | _aLeyton, Marco | |
| 773 | 0 |
_tBiological psychiatry _gvol. 76 _gno. 1 _gp. 23-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopsych.2013.08.033 _zAvailable from publisher's website |
| 999 |
_c23183583 _d23183583 |
||